2012
DOI: 10.1155/2012/864907
|View full text |Cite
|
Sign up to set email alerts
|

Autoimmune Thyroid Disease in Rheumatoid Arthritis: A Global Perspective

Abstract: Objective. To determine the prevalence and impact of autoimmune thyroid disease (AITD) in patients with rheumatoid arthritis (RA). Methods. Eight-hundred patients were included. The association between AITD and RA was analyzed was analyzed by bivariate and multivariate analysis. In addition, a literature review was done focusing on geographical variations. Results. In our cohort the prevalence of AITD was 9.8% while the presence of antibodies was 37.8% for antithyroperoxidase enzyme (TPOAb) and 20.8% for antit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

4
57
1
9

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 78 publications
(83 citation statements)
references
References 103 publications
4
57
1
9
Order By: Relevance
“…The prevalence of thyroid disorders noted in a Colombian cohort of RA patients was 9.8% (mean age 51.92, n=800) with higher levels of thyroid antibodies (28 (29). Moreover, the prevalence was higher in patients with early RA (6-24 months).…”
Section: N Discussion and Conclusionmentioning
confidence: 89%
“…The prevalence of thyroid disorders noted in a Colombian cohort of RA patients was 9.8% (mean age 51.92, n=800) with higher levels of thyroid antibodies (28 (29). Moreover, the prevalence was higher in patients with early RA (6-24 months).…”
Section: N Discussion and Conclusionmentioning
confidence: 89%
“…The number of patients with hypothyroidism and hyperthyroidism were 4.3%. A literature review disclosed a geographical variation of thyroid disease in RA ranging from 0.5% to 27% [31].…”
Section: Discussionmentioning
confidence: 99%
“…При наличии у пациента аТПО и/или аТГ и нор-мальном гормональном статусе говорят только об «им-мунологических нарушениях», хотя такие больные ос-таются в группе риска развития АЗЩЖ в дальнейшем [27,28].…”
unclassified
“…Частота АЗЩЖ при РА в разных странах колеблется от 0,5 до 27%, еще чаще у больных РА наблюдается продук-ция органоспецифических аутоантител: аТПО (5-38%), аТГ (6-31%) [28][29][30][31][32].…”
unclassified
See 1 more Smart Citation